0001965301-23-000084.txt : 20230731
0001965301-23-000084.hdr.sgml : 20230731
20230731162523
ACCESSION NUMBER: 0001965301-23-000084
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20230731
DATE AS OF CHANGE: 20230731
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Roivant Sciences Ltd.
CENTRAL INDEX KEY: 0001635088
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981173944
STATE OF INCORPORATION: D0
FISCAL YEAR END: 0331
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-40782
FILM NUMBER: 231127693
BUSINESS ADDRESS:
STREET 1: CLARENDON HOUSE, 2 CHURCH STREET
CITY: HAMILTON HM11
STATE: D0
ZIP: HM11
BUSINESS PHONE: 441-295-5950
MAIL ADDRESS:
STREET 1: CLARENDON HOUSE
STREET 2: 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Venker Eric
CENTRAL INDEX KEY: 0001801917
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: C/O ROIVANT SCIENCES, INC.
STREET 2: 320 WEST 37TH STREET, 6TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
144
1
primary_doc.xml
144
0001801917
XXXXXXXX
LIVE
0001635088
Roivant Sciences Ltd.
001-40782
CLARENDON HOUSE, 2 CHURCH STREET
HAMILTON HM11
D0
HM11
441-295-5950
Venker Eric
Officer
Common
Rockefeller Financial LLC
45 Rockefeller Plaza - Floor 5
New York
NY
10111
117372
1397752.56
766811433
07/31/2023
Nasdaq
Common
07/31/2023
Options Exercise - Grant Date 4/20/2022
Roivant Sciences Ltd.
N
117372
07/31/2023
Wire
N
Eric Venker
c/o Roivant Sciences Ltd. 7th Floor
50 Broadway
London
X0
SW1H 0DB
Common
05/01/2023
61155
525251.75
Eric Venker
c/o Roivant Sciences Ltd. 7th Floor
50 Broadway
London
X0
SW1H 0DB
Common
05/02/2023
109074
897477.32
Eric Venker
c/o Roivant Sciences Ltd. 7th Floor
50 Broadway
London
X0
SW1H 0DB
Common
05/03/2023
118760
997196.40
Eric Venker
c/o Roivant Sciences Ltd. 7th Floor
50 Broadway
London
X0
SW1H 0DB
Common
05/04/2023
88838
737504.16
Eric Venker
c/o Roivant Sciences Ltd. 7th Floor
50 Broadway
London
X0
SW1H 0DB
Common
05/08/2023
61206
546237.33
Eric Venker
c/o Roivant Sciences Ltd. 7th Floor
50 Broadway
London
X0
SW1H 0DB
Common
05/09/2023
238724
2204059.84
Eric Venker
c/o Roivant Sciences Ltd. 7th Floor
50 Broadway
London
X0
SW1H 0DB
Common
05/23/2023
15671
150128.18
Eric Venker
c/o Roivant Sciences Ltd. 7th Floor
50 Broadway
London
X0
SW1H 0DB
Common
05/23/2023
415
4087.75
Eric Venker
c/o Roivant Sciences Ltd. 7th Floor
50 Broadway
London
X0
SW1H 0DB
Common
06/07/2023
201
1979.85
Eric Venker
c/o Roivant Sciences Ltd. 7th Floor
50 Broadway
London
X0
SW1H 0DB
Common
06/09/2023
299384
2967299.96
Eric Venker
c/o Roivant Sciences Ltd. 7th Floor
50 Broadway
London
X0
SW1H 0DB
Common
06/22/2023
15882
158978.82
Eric Venker
c/o Roivant Sciences Ltd. 7th Floor
50 Broadway
London
X0
SW1H 0DB
common
07/20/2023
159387
1802034.65
Eric Venker
c/o Roivant Sciences Ltd. 7th Floor,
50 Broadway
London
X0
SW1H 0DB
Common
07/21/2023
181998
2025358.44
Eric Venker
c/o Roivant Sciences Ltd. 7th Floor
50 Broadway
London
X0
SW1H 0DB
Common
07/21/2023
28937
322068.81
Eric Venker
c/o Roivant Sciences Ltd. 7th Floor
50 Broadway
London
X0
SW1H 0DB
Common shares
07/24/2023
16297
179104.03
Eric Venker
c/o Roivant Sciences Ltd. 7th Floo
50 Broadway
London
X0
SW1H 0DB
Common Shares
07/24/2023
33081
361645.23
Eric Venker
c/o Roivant Sciences Ltd. 7th Floor
50 Broadway
London
X0
SW1H 0DB
Common shares
07/25/2023
28344
307869.19
Eric Venker
c/o Roivant Sciences Ltd. 7th Floor
50 Broadway
London
X0
SW1H 0DB
common shares
07/26/2023
28344
307869.19
Eric Venker
c/o Roivant Sciences Ltd. 7th Floor,
50 Broadway
London
X0
SW1H 0DB
common shares
07/27/2023
23622
259448.15
The shares reported on this Form 144 will be sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 02/25/2023.
07/31/2023
02/25/2023
Audrey Skillern as a duly authorized representative of National Financial Services LLC, as attorney-in-fact for Eric Venker